U.S. e-cigarette suppliers told to stop claiming official approval

Vaperz not tested by FDA disclaimer 300x180The U.S. Food and Drug Administration (FDA) has ordered three e-cigarette suppliers to stop falsely claiming that their products are FDA-endorsed.

In the first warning letters of their kind, the FDA wrote to the companies – Dr. K, Knoxville Vapor, and Vaperz – to tell them that they are violating section 301 of the U.S. Federal Food Drug & Cosmetic Act by suggesting to consumers that their products have been approved by the FDA.

“General examples of the violations include claims of FDA lab certification (Knoxville Vapor) and FDA registration/approval (Vaperz Ltd. and Dr. K),” the agency said today.

The firms now have 15 days to reply with details of the action they are taking in response, or could face civil penalties, injunction, or criminal prosecution.

Subscribe to our Newsletter

Join in to hear about news, events, and podcasts in the sector

    See more

    The Websites of both Knoxville Vapor and Vaperz today included statements that their products had not been reviewed by the FDA.

    What This Means: This is business as usual for the FDA, which was at pains to stress that it had taken action because the companies had made claims of federal approval for tobacco products – and that the warnings have nothing to do with the agency’s plans to regulate e-cigarettes through its deeming rules.

    All the same, it underlines the importance for the industry as a whole of distancing itself – not least in the eyes of the FDA – from suppliers which put forward unsupportable or misleading ideas.

    – Barnaby Page ECigIntelligence staff

    Barnaby Page

    Editorial director
    Before joining ECigIntelligence in early 2014 as one of its first employees, Barnaby had a 30-year career as a reporter and editor for newspapers, magazines and online services, working in Canada, the US and the Middle East as well as his current British location. He has edited publications covering fields including technology and the advertising industry, and was launch editor of the first large daily online news service in the British regional media. Barnaby also writes on classical music and film for a number of publications. Barnaby manages the editorial and reporting teams and works closely with the analyst teams, to ensure that all content meets high standards of quality and relevance. He also writes for the site occasionally, mostly on science-related issues, and is a member of the Association of British Science Writers.

    Our Key Benefits

    The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

    ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

    • Stay informed of any legal and market change in the sector that impacts your organisation
    • Maximise resources by getting market and legal data analysis daily in one place
    • Make smart decisions by understanding how the regulatory and market landscape evolves
    • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization